|
All (%)
|
Age (%)
|
P-value
|
Odds ratio confidence interval 95%
|
Sex (%)
|
P-value
|
Odds ratio confidence interval 95%
|
Acute myocardial infarction (%)
|
P-value
|
Odds ratio confidence interval 95%
|
---|
≤ 73
|
> 73
|
Women
|
Men
|
Yes
|
No
|
---|
Complete vital signs registered
|
1950 (93)
|
970 (92)
|
980 (94)
|
0.031
|
1.04–2.07
|
988 (94)
|
962 (93)
|
0.336
|
0.60–1.19
|
231 (91)
|
1719 (94)
|
0.127
|
0.44–1.11
|
ECG registered
|
2011 (96)
|
1008 (96)
|
1003 (97)
|
0.241
|
0.84–2.05
|
1024 (97)
|
987 (95)
|
0.015
|
0.36–0.90
|
249 (98)
|
1762 (96)
|
0.101
|
0.86–5.36
|
Medical treatment
| | | | | | | | | | | | | |
Oxygena
|
54 (90)
|
8 (89)
|
46 (90)
|
0.904
|
0.12–11.18
|
26 (93)
|
28 (88)
|
0.495
|
0.09–3.19
|
10 (77)
|
44 (94)
|
0.095
|
0.04–1.30
|
Acetylsalicylic acid
|
587 (28)
|
311 (39)
|
276 (27)
|
0.138
|
0.715–1.05
|
253 (24)
|
334 (32)
|
< 0.001
|
1.24–1.82
|
127 (50)
|
460 (25)
|
< 0.001
|
2.29–3.92
|
Sublingual glyceryl trinitrateb
|
659 (53)
|
354 (53)
|
305 (54)
|
0.708
|
0.83–1.31
|
323 (52)
|
336 (55)
|
0.355
|
0.89–1.39
|
95 (59)
|
564 (53)
|
0.105
|
0.94–1.85
|
Oxycodoneb
|
484 (39)
|
255 (38)
|
229 (41)
|
0.387
|
0.88–1.39
|
212 (34)
|
272 (44)
|
< 0.001
|
1.22–1.93
|
87 (54)
|
397 (37)
|
< 0.001
|
1.45–2.84
|
Ondansetronc
|
177 (33)
|
101 (31)
|
76 (36)
|
0.246
|
0.86–1.79
|
95 (31)
|
82 (35)
|
0.358
|
0.83–1.70
|
33 (52)
|
144 (30)
|
0.001
|
1.50–4.33
|
- Univariate logistic regression analyses. Analyses on treatment with oxygen, sublingual glyceral trinitrate, oxycodone and odansetron excuted on subgroups based on signs and symptoms as stated below
- ECG = Electrocardiogram
- a if oxygen satuartion < 90% (60 patients)
- b if patient rated pain according to NRS > 3 (1234 patients)
- c if patient reported nausea (540 patients)